An alternative treatment strategy for pump thrombus in the DeBakey VAD Child: use of clopidogrel as a thrombolytic agent.
Our institution has used the DeBakey VAD Child as a bridge to heart transplantation in select pediatric patients. Pump thrombus is a potentially serious complication with few available treatment options. Only surgical device exchange or the use of tissue plasminogen activator are reported in the literature. We report the use of clopidogrel as an alternative thrombolytic agent in the presence of pump thrombus in an adolescent patient with a DeBakey VAD Child heart pump.
Studer
Matthew A
MA
Lillie Frank Abercrombie Section of Pediatric Cardiology, Department of Pediatrics (Cardiology, Critical Care), Baylor College of Medicine and Texas Children's Hospital, 6621 Fannin, MC 19345-C, Houston 77030, USA. mastuder@texaschildrenshospital.org
Kennedy
Curtis E
CE
Dreyer
William J
WJ
Price
Jack F
JF
Moffett
Brady S
BS
Teitel
Edward R
ER
Carberry
Kathleen E
KE
Morales
David L S
DL
McKenzie
E Dean
ED
Chang
Anthony C
AC
D000293:Adolescent; D001241:Aspirin / Q000627:therapeutic use; D002311:Cardiomyopathy, Dilated / Q000601:surgery; D000077144:Clopidogrel; D004868:Equipment Failure; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D016027:Heart Transplantation; D006353:Heart-Assist Devices / Q000009:adverse effects*; D006801:Humans; D008297:Male; D013927:Thrombosis / Q000188:drug therapy* / Q000209:etiology*; D013988:Ticlopidine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D014859:Warfarin / Q000627:therapeutic use
D005343:Fibrinolytic Agents; D014859:Warfarin; D000077144:Clopidogrel; D013988:Ticlopidine; D001241:Aspirin